Middle East & Africa Central Lab Market Size & Outlook

The central lab market in Middle East & Africa is expected to reach a projected revenue of US$ 206.9 million by 2030. A compound annual growth rate of 6.2% is expected of Middle East & Africa central lab market from 2025 to 2030.
Revenue, 2024 (US$M)
$145.5
Forecast, 2030 (US$M)
$206.9
CAGR, 2025 - 2030
6.2%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa central lab market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

MEA central lab market highlights

  • The MEA central lab market generated a revenue of USD 145.5 million in 2024.
  • The market is expected to grow at a CAGR of 6.2% from 2025 to 2030.
  • In terms of segment, biomarker services was the largest revenue generating services in 2024.
  • Genetic Services is the most lucrative services segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.


MEA data book summary

Market revenue in 2024USD 145.5 million
Market revenue in 2030USD 206.9 million
Growth rate6.2% (CAGR from 2025 to 2030)
Largest segmentBiomarker services
Fastest growing segmentGenetic Services
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationGenetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services
Key market players worldwideLabConnect, Eurofins Scientific SE, A. P. Moller Maersk A/S ADR, ACM Global, Cerba Research, Synevo Central Labs, Versiti, Cenetron, Ampersand Capital Partners, Pacific Biomarkers, Cirion


Other key industry trends

  • In terms of revenue, MEA region accounted for 4.2% of the global central lab market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,201.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Central Lab Market Companies

Name Profile # Employees HQ Website
Cirion View profile 101-250 Laval, Quebec, Canada, North America https://www.cirion.com
Pacific Biomarkers View profile 51-100 Seattle, Washington, United States, North America http://www.pacbio.com
Ampersand Capital Partners View profile 11-50 Wellesley, Massachusetts, United States, North America http://www.ampersandcapital.com
Cenetron View profile 101-250 Austin, Texas, United States, North America https://www.cenetron.com/
Versiti View profile 1001-5000 Milwaukee, Wisconsin, United States, North America https://www.versiti.org/
Synevo Central Labs View profile - Waterloo, Brabant Wallon, Belgium, Europe http://www.synevo-centrallabs.eu
Cerba Research View profile 5001-10000 Ghent, Oost-Vlaanderen, Belgium, Europe https://www.cerbaresearch.com
ACM Global View profile 251-500 Rochester, New York, United States, North America http://www.acmgloballab.com
LabConnect View profile 101-250 Johnson City, Tennessee, United States, North America https://www.labconnect.com/
A. P. Moller Maersk A/S ADR View profile 100000 Esplanaden 50, Copenhagen, Denmark, 1263 https://www.maersk.com
Eurofins Scientific SE View profile 61798 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 https://www.eurofins.com

Middle East & Africa central lab market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central lab market will help companies and investors design strategic landscapes.


Biomarker services was the largest segment with a revenue share of 40.89% in 2024. Horizon Databook has segmented the Middle East & Africa central lab market based on genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services covering the revenue growth of each sub-segment from 2018 to 2030.


Middle East & Africa represents an emerging market with a promising future for central labs due to its large size, large population, and increasing economic growth. The region is marked by the presence of diverse ethnic groups, which can offer genetic diversity to attract various clinical trials and genetic studies. 

These factors are expected to contribute to the growth of several testing services in the region, thereby boosting the growth of central lab market over the forecast period. 

However, the region suffers from limited availability of infrastructure, essential equipment & qualified personnel, cultural barriers in conducting clinical studies, and uncertainty in clinical trial regulatory timelines, which may impede the market growth.

Reasons to subscribe to Middle East & Africa central lab market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa central lab market databook

  • Our clientele includes a mix of central lab market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa central lab market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa central lab market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA central lab market size, by country, 2018-2030 (US$M)

Middle East & Africa Central Lab Market Outlook Share, 2024 & 2030 (US$M)

MEA central lab market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online